what actually is cryptocurrency Top Featured snippets

CICC looks forward to the insurance industry in 2025: investment opportunities may be easy first and then difficult. When CICC looks forward to the insurance industry in 2025, it said that it is expected that the stock market and policy expectations will still be the short-term main drivers of the stock price of the sector. Combined with the low profit base and the possible window period, the investment opportunities in the industry may be easy first and then difficult: the short-term stock market will rise sharply or reproduce the general market, and the investment logic will return to long-term contradictions such as interest rate trends after emotional calm.Australia's unemployment rate in November was 3.93%, which is estimated to be 4.2%.South Korean President Yin Xiyue appeared in the office on Thursday for the first time in five days.

China Bank's RMB clearing volume in Australia exceeded 100 trillion yuan. According to Bank of China, recently, Bank of China Sydney Branch and Bank of China Hong Kong jointly held a RMB forum in Sydney to celebrate the 10th anniversary of being an Australian RMB clearing bank. As the only RMB clearing bank in the South Pacific at present, in the past ten years, China Bank has taken root in Australia and South Pacific, continuously expanded its clearing network, cooperated with four local banks and other financial institutions in Australia, and became the main channel for RMB clearing of local important banks, providing RMB clearing volume of more than 100 trillion yuan.Rosario Grain Exchange: Argentina's wheat production in 2024/25 is estimated to be 19.3 million tons, compared with the previous estimate of 18.8 million tons.List of A-share share repurchase: 16 companies disclosed the progress of repurchase, and on December 12, a total of 16 companies issued announcements related to share repurchase. Among them, four companies disclosed the stock repurchase plan for the first time, two companies' repurchase plans were approved by the shareholders' meeting, four companies disclosed the implementation progress of stock repurchase, and six companies' repurchase plans have been implemented. Judging from the initial disclosure of the repurchase plan, the amount of a company's stock repurchase plan on that day exceeded 10 million. Nanshan aluminum, Longzhu Science and Technology and Longzhu Science and Technology have the highest repurchase plans, and they plan to repurchase no more than 600 million yuan, 5,895,100 yuan and 1,171,000 yuan respectively. Judging from the repurchase plan passed by the shareholders' meeting, the repurchase plans of two companies exceeded 10 million on that day. Huaan Securities and Tongkun have the highest repurchase amount, with the planned repurchase not exceeding 200 million yuan and 51,966,700 yuan respectively. Judging from the implementation progress of repurchase, Shunluo Electronics, Shengquan Group and Hailiang have the highest repurchase amounts, with 9.009 million yuan, 3.8251 million yuan and 3.5187 million yuan respectively. Judging from the completed repurchase, the repurchase amount of four companies on that day exceeded 10 million. Chengda Pharmaceutical Co., Ltd., Jinshi Resources Co., Ltd. and Yingfangwei Co., Ltd. have completed the highest repurchase amounts, with 57,061,600 yuan, 53,158,000 yuan and 31,405,600 yuan respectively.

The tenth batch of national procurement officially opened, and the number of enterprises and varieties involved reached a record high. The tenth batch of centralized drug procurement organized by the state officially accepted the application materials of enterprises at 8: 00 this morning at No.398 Zhanyuan Road, Nanqiao New Town, Fengxian District, Shanghai. This centralized procurement involved 62 varieties and 263 product specifications, and the number of enterprises and varieties involved reached a record high. Among them, 33 enterprises competed for nine short-listed oral sustained-release formulations of sitagliptin. There are also a number of varieties that are billions in the market of public hospitals, such as doxorubicin hydrochloride liposome injection, cefoperazone injection, piperacillin injection, compound α -ketoacid oral sustained-release dosage form, norepinephrine injection and aspirin oral sustained-release dosage form. The sales scale in sample hospitals last year all exceeded 2 billion yuan. Hengrui Pharma, Kelun Pharmaceutical, Unacon and Zhengda Tianqing participated with many varieties. Note: According to the tenth batch of national adoption documents released before, the tenth batch of national adoption rules have changed a lot, such as canceling the protection mechanism of 50% price reduction and increasing the fuse recovery mechanism by 1.8 times, and the number of B-certified enterprises affects the number of final finalists.South Korean President Yin Xiyue: The opposition party tried to paralyze the government. The opposition tried to get me out of office.Musk is worth $447 billion, nearly $200 billion behind Bezos. Tesla shares rose 5.9% on Wednesday to close at $424.77, a record high, surpassing the previous record of $409.97 set on November 4, 2021. According to the Bloomberg Billionaires Index, Musk's worth soared by $62.8 billion overnight to $447 billion, making him the first super-rich man on earth with a net worth of over $400 billion. Musk's current net worth is nearly $200 billion higher than that of the second-ranked Jeff Bezos, who is worth about $249 billion.